The net profit of 738,300 yuan in the first quarter of 2022 decreased by 93.13% year -on -year

On July 6, Capital State learned that Keyuan Bio (code: 873239.NQ) released the first quarter report performance report in 2022.

From January 1, 2022-March 31, 2022, the company realized operating income of 14.1339 million yuan, a decrease of 50.73%year-on-year, and net profit was 738,300 yuan, a year-on-year decrease of 93.13%, and the basic earnings per share were 0.0100 yuan.

The company's industry is chemical products.

During the company's reporting period, the total assets at the end of the period were 213 million yuan, operating profit was 80.12 million yuan, accounts receivable was 16.873 million yuan, and the net cash flow generated by operating activities was -46.124 million yuan.The cash was 14,017,300 yuan.

Keyuan Biological, the company, is called Jiangxi Keyuan Biological Co., Ltd., which was established on March 28, 2011. Liu Jianming, the current general manager, is the research and development, production and sales of tonsilic acid and derivative -related products.

- END -